Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?
Publication year
2019Source
Leukemia Research, 76, (2019), pp. 39-47ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Laboratory Medicine
Journal title
Leukemia Research
Volume
vol. 76
Page start
p. 39
Page end
p. 47
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [227881]
- Electronic publications [107344]
- Faculty of Medical Sciences [86219]
- Open Access publications [76465]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.